BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33515105)

  • 1. Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study.
    Gaudioso P; Borsetto D; Tirelli G; Tofanelli M; Cragnolini F; Menegaldo A; Fabbris C; Molteni G; Marchioni D; Nicolai P; Bossi P; Ciorba A; Pelucchi S; Bianchini C; Mauramati S; Benazzo M; Giacomarra V; Di Carlo R; Sethi M; Polesel J; Fussey J; Boscolo-Rizzo P
    Support Care Cancer; 2021 Aug; 29(8):4683-4691. PubMed ID: 33515105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic-nutritional index in HPV-negative head and neck squamous cell carcinoma treated with upfront surgery: a multi-institutional series.
    Tomasoni M; Piazza C; Deganello A; Bossi P; Tirelli G; Nicolai P; Da Mosto MC; Molteni G; Giacomarra V; Canzi P; Pelucchi S; Polesel J; Borsetto D; Boscolo-Rizzo P
    Acta Otorhinolaryngol Ital; 2023 Jun; 43(3):170-182. PubMed ID: 37204841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma.
    Jank BJ; Kadletz L; Schnöll J; Selzer E; Perisanidis C; Heiduschka G
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1487-1492. PubMed ID: 30877423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison and exploration of the prognostic value of the advanced lung cancer inflammation index, prognostic nutritional index, and systemic immune-inflammation index in newly diagnosed diffuse large B-cell lymphoma.
    Liu T; Ye F; Li Y; Liu A
    Ann Palliat Med; 2021 Sep; 10(9):9650-9659. PubMed ID: 34628890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
    Miyamoto N; Takenaka Y; Sudo T; Eguchi H; Tanaka H; Fukusumi T; Takemoto N; Suzuki M; Inohara H
    Acta Otolaryngol; 2023 Oct; 143(10):925-930. PubMed ID: 38059478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
    Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
    J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
    BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy.
    Zhang L; Zhao K; Kuang T; Wang K; Chai D; Qiu Z; Liu R; Deng W; Wang W
    BMC Cancer; 2023 Jan; 23(1):101. PubMed ID: 36717809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study.
    Boscolo-Rizzo P; D'Alessandro A; Polesel J; Borsetto D; Tofanelli M; Deganello A; Tomasoni M; Nicolai P; Bossi P; Spinato G; Menegaldo A; Ciorba A; Pelucchi S; Bianchini C; Cazzador D; Ramaciotti G; Lupato V; Giacomarra V; Molteni G; Marchioni D; Fabbris C; Occhini A; Bertino G; Fussey J; Tirelli G
    BMC Cancer; 2022 Mar; 22(1):243. PubMed ID: 35248020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factors and selection criteria in the retreatment of head and neck cancers.
    May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE
    Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
    Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
    Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
    Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab.
    Qi WX; Xiang Y; Zhao S; Chen J
    Cancer Immunol Immunother; 2021 Nov; 70(11):3199-3206. PubMed ID: 33796915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
    Patel U; Pandey M; Kannan S; Samant TA; Gera P; Mittal N; Rane S; Patil A; Noronha V; Joshi A; Patil VM; Prabhash K; Mahimkar MB
    Br J Cancer; 2020 Dec; 123(12):1757-1766. PubMed ID: 32939054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer.
    Atasever Akkas E; Erdis E; Yucel B
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3821-3830. PubMed ID: 37029321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer.
    Shiroyama T; Suzuki H; Tamiya M; Tamiya A; Tanaka A; Okamoto N; Nakahama K; Taniguchi Y; Isa SI; Inoue T; Imamura F; Atagi S; Hirashima T
    Cancer Med; 2018 Jan; 7(1):13-20. PubMed ID: 29150906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.